Vivos Therapeutics, Inc. (VVOS)

NASDAQ: VVOS · Real-Time Price · USD

2.070

-0.080 (-3.72%)

At close: Dec 5, 2025, 4:00 PM EST

2.060

-0.010 (-0.48%)

After-hours: Dec 5, 2025, 7:45 PM EST

Vivos Therapeutics Analyst Ratings

Total Analysts

2

Consensus Rating

Strong Buy

Price Target

$6.25

Upside

+201.93%

Ratings History

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Lucas Ward Ascendiant Capital	Ascendiant Capital	Strong Buy Maintains $6.5 → $5.5	Strong Buy	Maintains	$6.5 → $5.5	+165.70%	Dec 3, 2025
Yi Chen HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Initiates $7	Strong Buy	Initiates	$7	+238.16%	Nov 17, 2025
Lucas Ward Ascendiant Capital	Ascendiant Capital	Strong Buy Maintains $6.2 → $6.5	Strong Buy	Maintains	$6.2 → $6.5	+214.01%	Sep 9, 2025
Lucas Ward Ascendiant Capital	Ascendiant Capital	Strong Buy Maintains $6.6 → $6.2	Strong Buy	Maintains	$6.6 → $6.2	+199.52%	Apr 15, 2025
Lucas Ward Ascendiant Capital	Ascendiant Capital	Strong Buy Reiterates $6.6	Strong Buy	Reiterates	$6.6	+218.84%	Nov 20, 2024
Scott Henry Alliance Global Partners	Alliance Global Partners	Strong Buy Maintains $8.25 → $6	Strong Buy	Maintains	$8.25 → $6	+189.86%	Nov 19, 2024
Lucas Ward Ascendiant Capital	Ascendiant Capital	Strong Buy Maintains $6.4 → $6.6	Strong Buy	Maintains	$6.4 → $6.6	+218.84%	Aug 20, 2024
Edward Woo Ascendiant Capital	Ascendiant Capital	Strong Buy Initiates $63	Strong Buy	Initiates	$63	+2,919.32%	Jan 17, 2023
Scott Henry Roth Capital	Roth Capital	Strong Buy Maintains $275 → $250	Strong Buy	Maintains	$275 → $250	+11,977.29%	Aug 13, 2021
Scott Henry Roth Capital	Roth Capital	Strong Buy Maintains $300 → $275	Strong Buy	Maintains	$300 → $275	+13,185.02%	May 18, 2021
Alexander Nowak Craig-Hallum	Craig-Hallum	Strong Buy Initiates $300	Strong Buy	Initiates	$300	+14,392.75%	Jan 11, 2021
Scott Henry Roth Capital	Roth Capital	Strong Buy Initiates $300	Strong Buy	Initiates	$300	+14,392.75%	Jan 5, 2021